Politics and Policy

Weekend Reading: FDA’s Rollout of Plasma EUA Draws Skepticism

August 24, 2020

Scientists react negatively to FDA's handling of the Emergency Use Authorization for convalescent plasma in COVID-19.

How Will Real-World Evidence Help Drive Solutions for COVID-19?

July 19, 2020

How real-world evidence will help FDA develop a vaccine.

Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners

July 05, 2020

FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.

Stark, Anti-Kickback Statute Reform: 5 Things Healthcare Execs Need to Know

October 17, 2019

In a long-awaited move, HHS proposes to overhaul the federal anti-kickback statute and Stark Law for today’s value-based environment.

Do Certificate-of-Need Laws Still Make Sense in 2019?

September 03, 2019

They were formed to provide greater access to healthcare and lower costs, but they may be doing more harm than good.

Nine Reasons Health Execs Are Excited for the Future

August 26, 2019

From new models to AI, the things that get health execs excited about the future of healthcare.

Price Transparency Rule Could Pose Challenges

August 09, 2019

Two challenges providers may face under the proposed rule.

What Trump’s Kidney Executive Order Means for Healthcare

July 28, 2019

How the president’s Advancing American Kidney Health’ Initiative will impact policy.

New York Not-For-Profit Nursing Home Sales are Subject to Increased Scrutiny by the Attorney General

July 26, 2019

Due, at least in part, to the substantial increase in the number of sales of New York not-for-profit skilled nursing facilities to for-profit operators since 2015, the Charities Bureau of the New York State Attorney General is subjecting such transactions to increased scrutiny, including objecting to certain of such sales, increasing the time and cost associated with such transactions.

Seven Pharmacy Regulations Health Execs Must Watch

June 13, 2019

These are the important policies to watch out for in 2019.

The Future of Stark Law

June 03, 2019

In the three decades since its passage, Stark Law has become one of the most significant sources of regulatory burden on physicians and, ultimately, for Medicare beneficiaries.

Hospitals Charge Employer Plans Double What Medicare Pays

May 18, 2019

A new RAND study uncovers significant differences between healthcare costs paid by privately insured patients and those paid out by Medicare.

The Potential Costs of Healthcare Price Transparency

May 15, 2019

A proposed policy calling for hospitals to publicly disclose negotiated prices charged for services is drawing ire from some hospitals and insurance companies.

Six Mid-Year Healthcare Trends to Watch

May 14, 2019

From disruptive technology to regulatory ‘known-unknowns’ to the plight of today’s healthcare consumer, 2019 is shaping up to be a year of extraordinary transformation.

The Future of Referencing Pricing in the U.S.

May 11, 2019

The United States pays much higher drug prices than other countries. Could reference pricing be the fix?

The Future of the ACA

April 12, 2019

Healthcare experts weigh in on what we can expect in 2019 and beyond.

Patient Control Over Health Data: Experts React

March 25, 2019

The ONC and CMS medical information transparency rule for patients, providers, and insurers may be the biggest change in healthcare system operations since the ACA. Here’s what to expect.

Why Healthcare Spending Is Rising Faster Than GDP

February 21, 2019

HCCI Releases 2017 Health Care Cost and Utilization Report. Here are the revealing findings.

Five Ways the Government Shutdown Will Affect Healthcare

January 23, 2019

While the government shutdown doesn’t directly affect HHS, the shutdown is having profound and long-lasting effects on the U.S. healthcare system.

Top 4 Challenges Healthcare Executives Face in 2019

January 11, 2019

Here’s what healthcare organizations will face in the year ahead, and expert advice on how to deal.